Darzalex SC (daratumumab)

pCPA File Number: 23530

Negotiation Status:

Under consideration for negotiation

Indication(s):

in combination with bortezomib, lenalidomide, and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are not candidates for autologous stem cell transplant.

Sponsor/Manufacturer:

Janssen Inc.

CDA-AMC Project Number:

PC0424-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable